欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Taltobulin_228266-40-8_产品详情
228266-40-8
  • names:

    Taltobulin

  • CAS号:

    228266-40-8

    MDL Number:
  • MF(分子式): C27H43N3O4 MW(分子量): 473.65
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Taltobulin
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000906-10mg 10mg 99.9% ¥ 4860.00 ¥ 4860.00 2-3天
- +
¥ 0.00
YZM000906-5mg 5mg 99.9% ¥ 2990.00 ¥ 2990.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 Taltobulin
CAS号 228266-40-8
Inchi
InchiKey
分子式 Formula C27H43N3O4
分子量 Molecular Weight 473.65
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(211.13 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionTaltobulin (HTI86; SPA10) is an analogue of Hemiasterlin; potent tubulin inhibitor; ADCs cytotoxin. IC50 value:
Application1
Application2
Application3
Taltobulin (HTI-286; SPA-110) is an analogue of Hemiasterlin; potent tubulin inhibitor; ADCs cytotoxin. IC50 value: Target: tubulin in vitro: HTI-286 significantly inhibited proliferation of all three hepatic tumor cell lines (mean IC50 = 2 nmol/L +/- 1 nmol/L) in vitro. Interestingly, no decrease in viable primary human hepatocytes (PHH) was detected under HTI-286 exposure [1]. In all cell lines tested, HTI-286 was a potent inhibitor of proliferation and induced marked increases in apoptosis. Despite similar transcriptomic changes regarding cell death and cell cycle regulating genes after exposure to HTI-286 or docetaxel, array analysis revealed distinct molecular signatures for both compounds [2]. in vivo: Intravenous administration of HTI-286 significantly inhibited tumor growth in vivo (rat allograft model) [1]. HTI-286 significantly inhibited growth of PC-3 and LNCaP xenografts and retained potency in PC-3dR tumors. Simultaneous castration plus HTI-286 therapy was superior to sequential treatment in the LNCaP model [2].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Vashist YK, et al. Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol. 2006 Nov 14;12(42):6771-8.
【2】.Hadaschik BA, et al. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. Int J Cancer. 2008 May 15;122(10):2368-76.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents